mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.
暂无分享,去创建一个
A. Weyrich | G. Zimmerman | L. Kraiss | K. Albertine | N. Tolley | H. Schwertz | T. McIntyre | M. Denis | Eliott D Spencer | J. Foulks
[1] Nigel Mackman,et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets , 2006, The Journal of experimental medicine.
[2] Ramin Massoumi,et al. Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.
[3] P. Libby,et al. Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.
[4] T. Dandekar,et al. Analysis of SAGE data in human platelets: Features of the transcriptome in an anucleate cell , 2006, Thrombosis and Haemostasis.
[5] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[6] B. Gersh. Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis: A Randomized Controlled Trial , 2006 .
[7] W. Ouwehand,et al. Platelet genomics and proteomics in human health and disease. , 2005, The Journal of clinical investigation.
[8] A. Rabson,et al. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase. , 2005, Biochemical and biophysical research communications.
[9] D. J. Moliterno. Healing Achilles--sirolimus versus paclitaxel. , 2005, The New England journal of medicine.
[10] K. Swoboda,et al. Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.
[11] J Wouter Jukema,et al. Drug-eluting stents: results, promises and problems. , 2005, International journal of cardiology.
[12] A. Weyrich,et al. Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. , 2005, Trends in cardiovascular medicine.
[13] H. Brogren,et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. , 2004, Blood.
[14] L. Rozek,et al. Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection. , 2004 .
[15] A. Weyrich,et al. Activated Polymorphonuclear Leukocytes Rapidly Synthesize Retinoic Acid Receptor-α , 2004, The Journal of experimental medicine.
[16] A. Weyrich,et al. Platelets: signaling cells in the immune continuum. , 2004, Trends in immunology.
[17] D. Dixon,et al. Change in protein phenotype without a nucleus: translational control in platelets. , 2004, Seminars in thrombosis and hemostasis.
[18] A. Weyrich,et al. Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Dushay,et al. Isolation and Characterization of Hemolymph Clotting Factors in Drosophila melanogaster by a Pullout Method , 2004, Current Biology.
[20] P. Noris,et al. Platelet-Independent defect in hemostasis associated with sirolimus use. , 2004, Transplantation proceedings.
[21] R. Dwek,et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. , 2004, Blood.
[22] R. Virmani,et al. Drug-eluting stents: are they really safe? , 2004, The American heart hospital journal.
[23] Dermot F. Reilly,et al. Integration of Proteomics and Genomics in Platelets , 2004, Molecular & Cellular Proteomics.
[24] A. Jaeschke,et al. mTOR: a mediator of intracellular homeostasis. , 2004, Current topics in microbiology and immunology.
[25] A. Weyrich,et al. The evolving role of platelets in inflammation , 2003, Journal of thrombosis and haemostasis : JTH.
[26] P. Perrotta,et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. , 2003, Blood.
[27] Eric J. Topol,et al. Scientific and therapeutic advances in antiplatelet therapy , 2003, Nature Reviews Drug Discovery.
[28] Zaverio M. Ruggeri,et al. Platelets in atherothrombosis , 2002, Nature Medicine.
[29] F. Welt,et al. Inflammation and Restenosis in the Stent Era , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[30] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[31] R. Jordan,et al. Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. , 2002, Journal of the American College of Cardiology.
[32] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[33] A. Weyrich,et al. Outside-In Signals Delivered by Matrix Metalloproteinase-1 Regulate Platelet Function , 2002, Circulation research.
[34] A. Weyrich,et al. Integrins Regulate the Intracellular Distribution of Eukaryotic Initiation Factor 4E in Platelets , 2001, The Journal of Biological Chemistry.
[35] D. Dixon,et al. Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Dixon,et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.
[37] A. Gingras,et al. Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.
[38] C. Vesin,et al. Beta2 integrin modulates platelet caspase activation and life span in mice. , 2001, European journal of cell biology.
[39] Jeffrey J. Popma,et al. Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2001, Circulation.
[40] B. Woda,et al. Expression of Translation Initiation Factors eIF-4E and eIF-2α and a Potential Physiologic Role of Continuous Protein Synthesis in Human Platelets , 2001, Thrombosis and Haemostasis.
[41] Y. Wu,et al. Differential activation and redistribution of c-Src and Fyn in platelets, assessed by MoAb specific for C-terminal tyrosine-dephosphorylated c-Src and Fyn. , 2000, Biochimica et biophysica acta.
[42] P. Bray,et al. The PlA2 polymorphism of integrin β3 enhances outside-in signaling and adhesive functions , 2000 .
[43] J. Savill,et al. Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis , 2000, The Journal of Biological Chemistry.
[44] C. Cierniewski,et al. Activity of pp60c‐src and Association of pp60c‐src, pp54/58lyn, pp60fyn, and pp72syk with the Cytosḱeleton in Platelets Activated by Collagen , 2000, IUBMB life.
[45] P. Bray,et al. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. , 2000, The Journal of clinical investigation.
[46] J. Pearson. Vascular Adhesion Molecules and Inflammation , 2012, Progress in Inflammation Research.
[47] J. Hartwig,et al. Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes , 1999, The Journal of cell biology.
[48] M. Bertagnolli,et al. Selective association of the tyrosine kinases Src, Fyn, and Lyn with integrin-rich actin cytoskeletons of activated, nonaggregated platelets. , 1999, Biochemical and biophysical research communications.
[49] R. Virmani,et al. Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.
[50] D. Dixon,et al. Integrin-dependent Control of Translation: Engagement of Integrin αIIbβ3 Regulates Synthesis of Proteins in Activated Human Platelets , 1999, The Journal of cell biology.
[51] G. Zimmerman,et al. Platelet-activating factor: A signaling molecule for leukocyte adhesion , 1999 .
[52] D. Dixon,et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Sher,et al. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.
[54] S. Jackson,et al. Calpain Cleavage of Focal Adhesion Proteins Regulates the Cytoskeletal Attachment of Integrin αIIbβ3 (Platelet Glycoprotein IIb/IIIa) and the Cellular Retraction of Fibrin Clots* , 1997, The Journal of Biological Chemistry.
[55] I. Verma,et al. Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.
[56] M. Simon,et al. Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.
[57] M. J. Danton,et al. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. , 1996, The EMBO journal.
[58] A. Weyrich,et al. Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.
[59] M. Ginsberg,et al. Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. , 1995, Blood.
[60] Hidenori Suzuki,et al. Involvement of Integrin in Mediating Fibrin Gel Retraction (*) , 1995, The Journal of Biological Chemistry.
[61] T. Hiroyama,et al. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction. , 1995, The Journal of biological chemistry.
[62] C. Mitchell,et al. Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers. , 1994, The Journal of biological chemistry.
[63] M. Lenardo,et al. Bcl-3-mediated nuclear regulation of the NF-кB trans-activating factor , 1994 .
[64] M. Lenardo,et al. Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor. , 1994, Immunology today.
[65] V. Bours,et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.
[66] G. FitzGerald,et al. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. , 1992, Blood.
[67] H. Ohno,et al. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control , 1990, Cell.
[68] D. Cheresh,et al. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells , 1989, Cell.
[69] J. White,et al. The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension. , 1989, Blood.
[70] G. Roth,et al. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. , 1989, Biochemical and biophysical research communications.
[71] J. Gorski,et al. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. , 1988, The Journal of clinical investigation.
[72] R. Colman. Hemostasis and thrombosis: Basic principles and clinical practice , 1987 .
[73] J. Fox. 3 – Platelet Contractile Proteins , 1986 .
[74] R. Taylor,et al. Platelets interact with fibrin only after activation. , 1985, Blood.
[75] D. Cove,et al. Platelet contractile proteins: separation and characterization of the actin and myosin-like components. , 1975, Journal of mechanochemistry & cell motility.